Migraine is a primary headache disorder diagnosed in children and adolescents with recurrent attacks of headache of moderate to severe intensity, typically bilaterally, with a throbbing quality, duration of 2 to 72 hours, and associated sensitivity to sensory stimuli, movement sensitivity, and potential for nausea and vomiting. Pediatric migraine is a common and potentially disabling disorder with an 8% to 24% prevalence in school-aged children.2 More than one-quarter of children with migraine report associated moderate or severe disability.3 Migraine may negatively affect school attendance, school performance, peer relationships, family dynamics, and mood. Migraine, when ineffectively treated, may result in transformation to a more bothersome chronic pain disorder.4
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Patniyot I, Qubty W. Short-term Treatment of Migraine in Children and Adolescents. JAMA Pediatr. Published online June 22, 2020. doi:10.1001/jamapediatrics.2020.1422
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: